B7H6 is the predominant activating ligand driving natural killer cell-mediated killing in patients with liquid tumours: evidence from clinical, in silico, in vitro, and in vivo studies
Sunyoung Lee, Seok Joo Chae, In-Hwan Jang, Se-Chan Oh, Seok-Min Kim, Soo Yun Lee, Ji Hyun Kim, Jesang Ko, Hang J Kim, Ik-Chan Song, Jae Kyoung Kim, Tae-Don Kim · 2024
Read B7H6 is the predominant activating ligand driving natural killer cell-mediated killing in patients with liquid tumours: evidence from clinical, in silico, in vitro, and in vivo studies by Sunyoung Lee, Seok Joo Chae, In-Hwan Jang, Se-Chan Oh, Seok-Min Kim, Soo Yun Lee, Ji Hyun Kim, Jesang Ko, Hang J Kim, Ik-Chan Song, Jae Kyoung Kim, Tae-Don Kim (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11621501.txt.
Description
Lee, Kim and their co-authors identify B7H6 as the main activating ligand that drives natural killer cells to kill liquid tumors in 2024. Natural killer cells can kill tumor cells, but which signals matter most was not clear.
The team combined data from patients, computer models, cell tests and mouse studies. In large cancer data, patients rich in natural killer cells and high in B7H6 fared distinctively. Cell line tests measured five major ligands and modeled each one's share of killing. Knockdown and added-expression tests backed the lead role for B7H6. Mouse models with tumors also supported targeting tumors rich in that ligand.
Catalog record
| CREATOR | Sunyoung Lee, Seok Joo Chae, In-Hwan Jang, Se-Chan Oh, Seok-Min Kim, Soo Yun Lee, Ji Hyun Kim, Jesang Ko, Hang J Kim, Ik-Chan Song, Jae Kyoung Kim, Tae-Don Kim |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 85 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |